CN113662068A - Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea - Google Patents
Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea Download PDFInfo
- Publication number
- CN113662068A CN113662068A CN202111033875.8A CN202111033875A CN113662068A CN 113662068 A CN113662068 A CN 113662068A CN 202111033875 A CN202111033875 A CN 202111033875A CN 113662068 A CN113662068 A CN 113662068A
- Authority
- CN
- China
- Prior art keywords
- effect
- medlar
- cinnamon
- ginger
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000017784 Mespilus germanica Nutrition 0.000 title claims abstract description 38
- 235000000560 Mimusops elengi Nutrition 0.000 title claims abstract description 38
- 235000007837 Vangueria infausta Nutrition 0.000 title claims abstract description 38
- 235000006886 Zingiber officinale Nutrition 0.000 title claims abstract description 16
- 235000008397 ginger Nutrition 0.000 title claims abstract description 16
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 15
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 14
- 244000273928 Zingiber officinale Species 0.000 title claims abstract 8
- 244000182216 Mimusops elengi Species 0.000 title claims abstract 7
- 238000002360 preparation method Methods 0.000 title claims description 11
- 235000019083 Osmanthus fragrans Nutrition 0.000 title description 2
- 244000242564 Osmanthus fragrans Species 0.000 title description 2
- 238000009472 formulation Methods 0.000 title description 2
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 45
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 42
- 235000020224 almond Nutrition 0.000 claims abstract description 35
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 34
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 34
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 30
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 27
- 240000000249 Morus alba Species 0.000 claims abstract description 21
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 10
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 10
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 244000088415 Raphanus sativus Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 88
- 206010011224 Cough Diseases 0.000 abstract description 21
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 16
- 244000241838 Lycium barbarum Species 0.000 abstract description 14
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 14
- 206010012735 Diarrhoea Diseases 0.000 abstract description 12
- 206010010774 Constipation Diseases 0.000 abstract description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 11
- 208000026435 phlegm Diseases 0.000 abstract description 11
- 208000006673 asthma Diseases 0.000 abstract description 8
- 210000004204 blood vessel Anatomy 0.000 abstract description 8
- 230000001976 improved effect Effects 0.000 abstract description 6
- 230000027939 micturition Effects 0.000 abstract description 6
- 206010039966 Senile dementia Diseases 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 3
- 230000036528 appetite Effects 0.000 abstract description 3
- 235000019789 appetite Nutrition 0.000 abstract description 3
- 206010000060 Abdominal distension Diseases 0.000 abstract description 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 2
- 208000035240 Disease Resistance Diseases 0.000 abstract description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 244000017020 Ipomoea batatas Species 0.000 abstract 1
- 235000002678 Ipomoea batatas Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 37
- 239000008280 blood Substances 0.000 description 37
- 240000002624 Mespilus germanica Species 0.000 description 31
- 241000220259 Raphanus Species 0.000 description 27
- 230000006870 function Effects 0.000 description 27
- 241000699670 Mus sp. Species 0.000 description 23
- 210000003734 kidney Anatomy 0.000 description 23
- 235000013399 edible fruits Nutrition 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 22
- 239000000284 extract Substances 0.000 description 21
- 241000700159 Rattus Species 0.000 description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 19
- 239000003814 drug Substances 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 241000283973 Oryctolagus cuniculus Species 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 13
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 12
- 229940089837 amygdalin Drugs 0.000 description 12
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 12
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 12
- 230000002496 gastric effect Effects 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 230000001603 reducing effect Effects 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 208000000059 Dyspnea Diseases 0.000 description 10
- 206010013975 Dyspnoeas Diseases 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 241000234314 Zingiber Species 0.000 description 8
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 8
- 229940117916 cinnamic aldehyde Drugs 0.000 description 8
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 208000004998 Abdominal Pain Diseases 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 206010067125 Liver injury Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000218231 Moraceae Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 208000031975 Yang Deficiency Diseases 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000010685 fatty oil Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 210000000582 semen Anatomy 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 244000241872 Lycium chinense Species 0.000 description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 5
- 102000057297 Pepsin A Human genes 0.000 description 5
- 108090000284 Pepsin A Proteins 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 230000004531 blood pressure lowering effect Effects 0.000 description 5
- 150000001746 carotenes Chemical class 0.000 description 5
- 235000005473 carotenes Nutrition 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 229960002591 hydroxyproline Drugs 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 229940111202 pepsin Drugs 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000916 dilatatory effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 231100000753 hepatic injury Toxicity 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 239000000413 hydrolysate Substances 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 229940118019 malondialdehyde Drugs 0.000 description 4
- 210000003470 mitochondria Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000036299 sexual function Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- DXIHILNWDOYYCH-UHDJGPCESA-M sodium;(e)-3-phenylprop-2-enoate Chemical compound [Na+].[O-]C(=O)\C=C\C1=CC=CC=C1 DXIHILNWDOYYCH-UHDJGPCESA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 229930003347 Atropine Natural products 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 244000018633 Prunus armeniaca Species 0.000 description 3
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
- 244000028419 Styrax benzoin Species 0.000 description 3
- 235000000126 Styrax benzoin Nutrition 0.000 description 3
- 235000008411 Sumatra benzointree Nutrition 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 3
- 229960000396 atropine Drugs 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 229960002130 benzoin Drugs 0.000 description 3
- 229940076810 beta sitosterol Drugs 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 235000019382 gum benzoic Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 235000021283 resveratrol Nutrition 0.000 description 3
- 229940016667 resveratrol Drugs 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 206010049077 Hernia pain Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000012404 In vitro experiment Methods 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000003746 Insulin Receptor Human genes 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 102000005686 Serum Globulins Human genes 0.000 description 2
- 108010045362 Serum Globulins Proteins 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 208000010553 multiple abscesses Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 229960001999 phentolamine Drugs 0.000 description 2
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 210000005084 renal tissue Anatomy 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 210000001186 vagus nerve Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- OOGFPFWTORZYAN-AQHGXSAQSA-N (2s,4r)-4-oxidanylpyrrolidine-2-carboxylic acid Chemical compound O[C@H]1CN[C@H](C(O)=O)C1.O[C@H]1CN[C@H](C(O)=O)C1 OOGFPFWTORZYAN-AQHGXSAQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZJVATSUMFCZSKA-QZOPMXJLSA-N (z)-docos-13-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O ZJVATSUMFCZSKA-QZOPMXJLSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 240000007371 Cuscuta campestris Species 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014476 Elevated cholesterol Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000007162 Ferula assa foetida Nutrition 0.000 description 1
- 244000228957 Ferula foetida Species 0.000 description 1
- 235000012850 Ferula foetida Nutrition 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 description 1
- 101710099339 Glucose-6-phosphatase catalytic subunit 1 Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- FEUWBELGELLWPV-UHFFFAOYSA-N Glycerol sinapate Natural products COC1=C(O)C(OC)=CC(C=CC(=O)OCC(COC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)OC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)=C1 FEUWBELGELLWPV-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 101150056637 Hrh2 gene Proteins 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010066364 Hypersexuality Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 241001299895 Microsporum ferrugineum Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 235000003893 Prunus dulcis var amara Nutrition 0.000 description 1
- 101500025285 Rattus norvegicus Submandibular gland peptide T Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010043994 Tonic convulsion Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 102100023038 WD and tetratricopeptide repeats protein 1 Human genes 0.000 description 1
- 208000009971 Walker Carcinoma 256 Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000008619 Xingren Substances 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 240000000038 Ziziphus mauritiana Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000008503 anti depressant like effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003171 anti-complementary effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003487 anti-permeability effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 229960003403 betaine hydrochloride Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- HOPSCVCBEOCPJZ-UHFFFAOYSA-N carboxymethyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(O)=O HOPSCVCBEOCPJZ-UHFFFAOYSA-N 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 229940002510 cinnamon preparation Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- ZKVJJVAZTBDPNW-UHFFFAOYSA-N ctk1d8407 Chemical compound NNNNN ZKVJJVAZTBDPNW-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 230000001909 effect on DNA Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- -1 flavanol polyphenol Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000000640 hydroxylating effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000035873 hypermotility Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 229940066294 lung surfactant Drugs 0.000 description 1
- 239000003580 lung surfactant Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000008779 ma-xing-shi-gan-tang Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 235000021084 monounsaturated fats Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 108700002722 mouse granuloma Proteins 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000001327 prunus amygdalus amara l. extract Substances 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000010825 rotarod performance test Methods 0.000 description 1
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000008546 sang ju yin Substances 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 229940076742 senna leaves Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000008783 wuzi yanzong Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a formula of a tea containing cassia, wolfberry, ginger and sweet potato, which comprises the following components in parts by weight: 0.25 part of cinnamon, 1.5 parts of medlar, 0.25 part of dried mulberry, 1 part of fried almond, 0.5 part of dried ginger, 1 part of honey-fried licorice root and 0.5 part of fried radish seed. The formula of the cinnamon, medlar, ginger and sweet tea disclosed by the invention adopts the raw materials, and the prepared tea has the following technical effects that 1, the vitality, the immunity and the disease resistance of middle-aged and elderly people are enhanced, and the activity endurance is improved; 2. relieving asthma, relieving cough, and eliminating phlegm; 3. softening blood vessel, delaying arteriosclerosis progression, and preventing senile dementia; 4. appetite is enhanced, and abdominal distension and constipation are relieved; 5. relieving diarrhea and frequent micturition.
Description
Technical Field
The invention relates to the field of health-care tea, in particular to a formula of cinnamon, medlar, ginger and sweet tea and a preparation method thereof.
Background
People's daily life, can't leave food, beverage, people's requirement to its taste and nutrition and special health function is also rising gradually, and the beverage, food kind on the market have been can't satisfy people's daily demand, and high nutrition and have certain health preserving health care food, beverage are more and more receiving consumers' favor.
Therefore, the formula of the cinnamon, medlar, ginger and sweet tea and the preparation method thereof become a technical problem to be solved urgently in the whole society.
Disclosure of Invention
In order to solve the technical problems, the technical scheme provided by the invention is as follows:
the formula of the cinnamon-wolfberry-ginger-sweet tea comprises the following components in parts by weight: 0.25 part of cinnamon, 1.5 parts of medlar, 0.25 part of dried mulberry, 1 part of fried almond, 0.5 part of dried ginger, 1 part of honey-fried licorice root and 0.5 part of fried radish seed.
Further, the method comprises the following preparation steps,
(1) preparing raw materials according to the weight parts, namely 0.25g of cinnamon, 1.5g of medlar, 0.25g of dried mulberry, 1g of fried almond, 0.5g of dried ginger, 1g of honey-fried licorice root and 0.5g of fried radish seed;
(2) the raw materials are ground into powder, and each bag is 5g, and the powder is taken with water.
Compared with the prior art, the invention has the advantages that: the formula of the cinnamon, medlar, ginger and sweet tea adopts the raw materials, and the prepared tea has the following technical effects:
1. enhance the vitality, immunity and disease resistance of the middle-aged and the elderly people, and improve the activity endurance;
2. relieving asthma, relieving cough, and eliminating phlegm;
3. softening blood vessel, delaying arteriosclerosis progression, and preventing senile dementia;
4. appetite is enhanced, and abdominal distension and constipation are relieved;
5. relieving diarrhea and frequent micturition.
Detailed Description
The present invention is described in further detail below.
The formula of the cinnamon-wolfberry-ginger-sweet tea comprises the following components in parts by weight: 0.25 part of cinnamon, 1.5 parts of medlar, 0.25 part of dried mulberry, 1 part of fried almond, 0.5 part of dried ginger, 1 part of honey-fried licorice root and 0.5 part of fried radish seed.
The preparation method comprises the following preparation steps of,
(1) preparing raw materials according to the weight parts, namely 0.25g of cinnamon, 1.5g of medlar, 0.25g of dried mulberry, 1g of fried almond, 0.5g of dried ginger, 1g of honey-fried licorice root and 0.5g of fried radish seed;
(2) the raw materials are ground into powder, and each bag is 5g, and the powder is taken with water.
The specific dosage table is as follows:
cinnamon bark
Pungent, sweet and big heat in property and flavor entering meridians. Enter the liver, kidney, heart, spleen and stomach meridians.
The efficacy application is as follows:
1. warming middle energizer and tonifying yang:
A. can be used for treating kidney-yang deficiency, deficiency and cold of lower-jiao, weakness of waist and feet, dysuresia, etc. It is indicated for decline of vital gate fire, cold limbs, slight pulse, yang exhaustion, collapse, abdominal pain, diarrhea, hernia of cold type, and cold pain in waist and knees.
B. Can be used for treating abdominal pain and diarrhea due to spleen-kidney yang deficiency.
2. Cold-dispelling pain-relieving, amenorrhea, deep rooted carbuncle of yin type, multiple abscess, floating of deficient yang, upper heat and lower cold.
A. Can be used for treating deficiency-cold type gastralgia, abdominal pain, and hernia pain.
B. Dysmenorrhea due to deficiency-cold. Can be used for treating sexual impotence, cold womb, psychroalgia of heart and abdomen, vomiting and diarrhea due to deficiency cold, amenorrhea, dysmenorrhea, and warming channels.
The main drug effect is as follows:
insufficiency of kidney-yang; fire at the gate of life intolerance of cold and cold limbs; soreness and weakness of waist and knees; impotence and spermatorrhea; dysuria or frequent urination; shortness of breath and dyspnea; edema and oliguria; decline of the fire from the life gate; fire does not return to the source; wearing the sun; geyang; and upper heat and lower cold; flushed face and cold feet; dizziness and tinnitus; the mouth and tongue are broken; deficiency-cold of spleen and kidney; abdominal cold pain; loose stool due to poor appetite; lumbago due to kidney deficiency; cold-dampness arthralgia; cold hernia pain; infertility due to cold womb; amenorrhea with dysmenorrhea; postpartum abdominal pain due to stasis; deep carbuncle of yin type and multiple abscess; or abscess with deficiency-cold without ulceration; or not astringing after ulceration
1. Action on the central nervous system cinnamaldehyde has an obvious sedative effect on mice, is manifested by reduced spontaneous activity, and can resist hypermotility caused by methamphetamine and dyskinesia generated by a rotarod test, and prolong the anesthesia time of the cyclohexylbarbital sodium. It is reported that when cinnamaldehyde is greater than 30mg/kg, spontaneous movement of mice can be inhibited, and when 60mg/kg of spontaneous movement is given, a slight increase in spontaneous movement is observed, and when cinnamaldehyde is given at more than 100mg/kg, hyperexcitability and inhibition are immediately observed. Reporters believe that the central effects of cinnamaldehyde may be an interaction of its monoamine neurofunctions and a tricyclic antidepressant-like effect. The mouse tail pressing method or the method of injecting acetic acid into abdominal cavity to twist body proves its pain relieving effect. Has cooling effect on normal body temperature of mice and artificial fever caused by typhoid and paratyphoid mixed vaccines. Cinnamic aldehyde and sodium cinnamate have antipyretic effect on fever caused by warm thorn. Cinnamic aldehyde can delay the time of ankylosing convulsion and death caused by strychnine; reduce the incidence of tonic convulsion and death caused by nicotine. But are not effective against pentaazan convulsions.
2. The effect on the cardiovascular system has reports that the cinnamon decoction is used for gastric perfusion and has an improvement effect on rabbit acute myocardial ischemia caused by pituitrin; can increase the coronary flow of the isolated heart of the guinea pig and can resist the reduction of the coronary flow of the isolated heart of the guinea pig caused by the posterior pituitary. The gastric administration of cinnamon water extract or cinnamon oil to rats can resist the change of cardiac function and hemodynamics caused by isoproterenol, and the cinnamon water extract is stronger than the cinnamon oil. The cinnamon preparation can fully improve diastolic pressure, correspondingly increase perfusion pressure of coronary artery and cerebral artery, promote collateral circulation of cardiac muscle and chest to open, thereby changing blood supply and presenting the effect of protecting cardiac muscle. Cinnamon is also reported to inhibit frog heart and dilate blood vessels, has an inhibitory effect on rabbit heart and can cause blood pressure reduction. Experiments prove that: sodium cinnamate has effects of dilating blood vessel of rabbit, and promoting blood circulation. The compound of monkshood and cinnamon has the function of reducing blood pressure of a rat with adrenal cortical hypertension formed by burning one side of adrenal gland; has no antihypertensive effect on renal hypertension rats formed by ligating the kidney. Cinnamic aldehyde and sodium cinnamate have dilating effect on frog web membrane blood vessel. Has direct dilating effect on peripheral blood vessel, and can reduce blood pressure and peripheral blood vessel resistance. Has temporary dilating effect on coronary artery and cerebral vessels.
3. The oleum Cinnamomi has effects of aromatizing, invigorating stomach, stimulating smell, promoting gastric function reflexively, and directly stimulating gastric mucosa, increasing secretion, and promoting peristalsis. The cassia oil is orally taken by rabbits, can promote intestinal movement and excite intestinal tracts, and has the same effect on isolated rabbit intestines.
The report shows that the cinnamon water extract has strong inhibition effect on rat ulcer caused by cold or water immersion stress by intraperitoneal injection, and the activity of the cinnamon water extract is the same as that of cimetidine. Cimetidine is not effective on ulcer caused by 5-hydroxytryptamine (5-HT), and cortex Cinnamomi selectively blocks H2 receptor of histamine, so that it has strong inhibitory effect on gastric secretion, and can increase blood flow of gastric mucosa and improve microcirculation, thereby inhibiting 5-HT ulcer. Cinnamon also reduces the gastric secretion of pylorus-ligated rats and promotes gastric mucosal blood flow. The mechanism of cinnamon antiulcer may be due to a decrease in the factors of ulcer activity (gastric juice and pepsin) and an increase in the factors of defense (gastric mucosal blood flow rate).
The cinnamon decoction is 20g/kg and is used for gastric perfusion of mice, so that the gastrointestinal propulsion rate of the mice can be obviously inhibited, and the diarrhea of the mice caused by senna leaves can be resisted; but not against the rate of gastrointestinal ink propulsion in phentolamine, morphine or atropine mice. When the weight is 5g/kg, the diarrhea effect of castor oil or senna mice is not obvious.
4. Other actions cassia oil has strong bactericidal action and better effect on gram-positive bacteria, but is rarely used as an antibacterial drug due to irritation. It can be used as stomachic and carminative agent for oral administration; it can be used for treating stomach ache and flatulence and colic by external application. Has strong fungus inhibiting effect, and can be mixed with thymol for treating porrigo. Cinnamic aldehyde and sodium cinnamate can increase rabbit leukocyte.
The cinnamon water extract is used for gastric perfusion of mice, can inhibit the atrophy of thymus of the mice with yang deficiency caused by glucocorticoid, and has protective effect on adrenal cortex function.
In vitro and in vivo experiments prove that: cinnamon has the obvious effect of inhibiting ADP-induced platelet aggregation of rats. In vitro experiments prove that: the cinnamon decoction and the water-soluble methanol have stronger anticoagulation effect.
The cinnamon, the realgar, the betel nut and the asafetida are used together to have a certain function of preventing schistosomiasis.
The diterpene components in cortex Cinnamomi have anticomplementary effect.
Clinical application of cinnamon
1. Can be used for the treatment of kidney yang deficiency, aversion to cold, cold limbs, spleen yang deficiency, abdominal pain, anorexia, diarrhea, and dyspepsia in the elderly.
2. Can be used for treating senile asthenia due to long-term illness, and qi and blood deficiency. The product has effects of activating spleen yang, and promoting blood circulation, and can be used for treating asthenia, qi deficiency, and blood deficiency due to long-term illness. A small amount of cinnamon is added into qi-tonifying and blood-nourishing herbs such as Dang Shen, Bai Zhu, Dang Gui and Shu Di Huang, so it can promote the growth of qi and blood.
Cinnamon contains flavanol polyphenol antioxidant substances, and can improve the stabilizing effect of insulin on blood sugar level and reduce insulin resistance. The way to achieve such functions is: activating an enzyme capable of stimulating an insulin receptor. ② the insulin signal path in the skeletal muscle tissue is more unblocked. Cinnamon has been found to contribute to the enhancement of insulin activity. The active ingredients in cinnamon contribute to the level of three key proteins: these proteins have important effects on insulin receptors, blood glucose transport and inflammatory responses, and thus can promote insulin activity or increase the body's sensitivity to insulin. In addition, it has been found that certain components of cinnamon have insulin-like properties and also contribute to the control of blood glucose levels.
The above-mentioned effects-improvement of blood glucose level, total cholesterol level, bad cholesterol and triglyceride level-can be obtained by eating about half a spoon of cinnamon per day. Moreover, the dosage is safe and reliable, and has no side effect.
Second, matrimony vine
[ PROPERTIES AND FLAVOURS ]: sweet in taste; the nature is mild.
[ meridian tropism ]: entering liver meridian; the kidney channel; the lung meridian.
[ Functions ]: nourishing the liver; nourishing kidney; moistening lung.
[ INDICATIONS ]: deficiency of the liver and kidney; light headedness; the vision is unclear; soreness and weakness of waist and knees; impotence and spermatorrhea; cough due to asthenia; thirst quenching and water drinking.
1. Impact on immune function: the Chinese wolfberry fruit injection has the effects of enhancing nonspecific immunity, and the Chinese wolfberry fruit water extract or intramuscular injection alcohol extract and Chinese wolfberry fruit polysaccharide are injected into mice, so that the phagocytic function of macrophages is improved, the effect of serum lysozyme is enhanced, the titer of anti-sheep red blood cell antibodies in serum is improved, and the number of anti-sheep red blood cell antibody forming cells in spleen of the mice can be increased.
2. The function of delaying senility: intragastric administration of 0.5mg/kg fructus Lycii extract in mice can obviously inhibit liver LPo generation in 20 days, and improve activity of blood glutathione peroxidase (GSH-Px) and erythrocyte superoxide dismutase (SOD); human body tests show that the Chinese wolfberry fruit extract can obviously inhibit the generation of serum LPo and increase the activity of GSH-Px in blood, but the activity of erythrocyte SOD is not increased, thus prompting that the Chinese wolfberry fruit extract has the function of delaying senility.
3. Anti-liver injury: the betaine hydrochloride can obviously increase the phospholipid in the serum and the liver of the rat, has obvious protective effect on the reduction of the phospholipid and the increase of the cholesterol of the rat caused by long-term carbon tetrachloride administration, and has similar effect but weaker effect on the water-soluble extract.
4. And (3) reducing blood sugar: the medlar extract can obviously and durably reduce the blood sugar of rats and increase the sugar tolerance, and has smaller toxicity. In addition, the product has antitumor and hemopoietic effects promoting effects.
5. The kidney tonifying function: li Xiao Mei, Wang Hai Yan, Li Liying, Mao Yao, Korea, Gunn, Hanjin, Li Mei Hua, Zhang Xiao Ying, Yuxia Jun are discussed in aging of aged rat kidney mitochondria and its drug protection: by observing the changes of the ultrastructure, ATP synthetic amount and the level of malondialdehyde which is a lipid peroxidation product of the renal cell mitochondria of the old mice after the application of the anti-aging drugs such as lycium barbarum polysaccharide, vitamin E-C mixture and the like, the structural and functional changes of the renal cell mitochondria of the old mice are found to be accompanied with the increase of malondialdehyde which is a free radical metabolite, the ATP synthetic amount of the renal cell mitochondria of the old mice is 120.38nM/mgPrmin +/-16.72 nM/mgPrmin and 18.75nM/mgPrmin lower than that of the young group; while the kidney tissue malondialdehyde is 30.40 μ g/100mg + -6.66 μ g/100mg wet weight, which is 2.4 times of that of the young group. After long-term administration of vitamin E-C mixture or Lycium barbarum polysaccharides, the composition has effects of resisting free radicals, reducing malondialdehyde level in kidney tissue, preventing mitochondrial aging, and improving functions.
Wolfberry fruit, a good product for nourishing liver and kidney. From the time when the poems are gathered in the bud medlar, the medlar is used for medicine, and the history of more than 3000 years is existed so far. The name of wolfberry fruit is originally recorded in Shen nong Ben Cao Jing and listed as the top grade, and is popular among people for hundreds of years. Jinzhu gehong is used for treating ophthalmic diseases by singly smashing the medlar into juice and dripping eyes; the Tang Dynasty sun Simiao uses the medlar to be matched with other medicines to prepare a liver tonifying pill for treating deficiency-cold of liver channel and dim and unclear eyes; the Wuzi Yanzong pill in Tang Dynasty Lizhu (entrance to medicine) is prepared with wolfberry fruit, dodder seed, etc. and through making honeyed bolus, taking with dilute saline water to treat male impotence, premature ejaculation, no fertility, early white beard and hair and no prohibition of urination and defecation. The medlar has unique function in the aspect of enhancing sexual function, and the famous Chinese folk that the circulation is very wide is 'Jun xing thousand miles, Moshi medlar', namely medlar has very strong function of exciting sexual function, and is not suitable for young men and women who are far away from home. However, it is necessary for men and women at home and those with impaired sexual function to eat more lycium barbarum or its preparations. For people with kidney deficiency, the wolfberry is undoubtedly the most popular delicious and wonderful medicine and is an rare health-care nutrient. The medlar is the best choice for preserving health in ancient times and modern times and has the effect of prolonging life. Doctors of all generations pay more attention to the effect of nourishing liver and kidney of the medlar, and in recent years, people have further knowledge on the chemical components and pharmacological action of the medlar, and the application range of the medlar is expanded clinically.
6. Liver protection function: the research on the morphological research of the liver injury repair effect of wolfberry polysaccharide on mice caused by carbon tetrachloride shows that the Bingluan, Shensheng, Wang Yan Rong, Guo Feng Ying and Zhangyan have the following effects: the 48 male Kunming mice were divided into 4 groups, and the group with liver injury (12) was given a subcutaneous injection of CCl 4; the group of liver injury saline (12) was gavaged with physiological saline for 7d in addition to CCl 4; the control group (12) was perfused with saline and tap water subcutaneously. Results the treatment group had a reduced lesion area of hepatic lobules, reduced lipid droplets in hepatocytes, increased nuclei, increased RNA and nucleoli, increased glycogen, increased SDH, G-6-Pase activity, restored bottled arrangement of rough endoplasmic reticulum, restored mitochondrial morphology and increased number compared to the lesion group and the lesion saline group. The lycium barbarum polysaccharide has a repairing effect on liver injury, and the mechanism of the lycium barbarum polysaccharide is probably to promote protein synthesis and detoxification by preventing the damage of endoplasmic reticulum, recover the function of liver cells and promote the regeneration of the liver cells.
7. Anti-fatty liver effect
Long-term (75 days) oral administration of betaine in the fruits of rats can increase the phospholipid level in blood and liver; the reduction of phospholipid and total cholesterol content in rat liver caused by carbon tetrachloride can be resisted and improved by taking betaine in advance or simultaneously; has effects in improving BSP, SGP-T, alkaline phosphatase, cholinesterase, etc. It is primarily betaine that acts as a methyl donor in the body.
Effects on blood pressure
The intravenous injection of 20mg/kg of the fruit water-soluble extract can reduce the blood pressure of the anesthetized rabbits and excite the respiration; the blood pressure lowering effect can be eliminated by cutting off vagus nerves on two sides by injecting atropine; inhibiting heart of isolated rabbit, contracting blood vessel of rabbit ear, and slightly lowering blood pressure of organic solvent extract such as methanol and acetone.
8. Anti-fatigue effect
The influence of the medlar decoction on the hydroxyproline content and the hypoxia tolerance and fatigue resistance of mice:
hydroxyproline (Hydroxyproline) is an amino acid in collagen fibers and proteins and is obtained by hydroxylating proline. In the aging process of human body, due to insufficient oxygen supply, the hydroxylation process of proline is affected, so that the content of hydroxyproline in collagen of the old is low, the main organs are reduced in size and shape, and the weight is reduced. Due to the influence of lung function, the lung capacity is reduced, the reserve capacity is reduced, the resistance is reduced, the muscle strength is reduced, and the hypoxia tolerance and the fatigue resistance are reduced. Hydroxyproline content is therefore relevant for aging. The fructus Lycii decoction (13.23% concentration) is administered to mice by intragastric administration at a dose of 0.3ml/20g, 1 time per day, and the hydroxyproline concentration after 30 days is increased by 15.49% compared with control. The medlar decoction is injected into the abdominal cavity of a mouse with 0.3ml/20g, compared with the control group with the survival time of 27.9 plus or minus 1.3 minutes, the medlar has the survival time of 37.5 plus or minus 2.5 minutes (P is less than 0.01). The anti-fatigue test and the comparison of the control also have very significant difference (P < 0.01).
Anti-tumor effect
In vitro experiments show that the medlar and leaves have obvious inhibition effects on human gastric adenocarcinoma KATO-III cells and medlar carpopodium and leaves on human cervical carcinoma Hela cells, and the action mechanism of the medlar and leaves mainly shows that the medlar and leaves inhibit cell DNA synthesis, interfere cell division and reduce cell reproduction capability. The medlar freeze-dried powder suspension and cyclophosphamide are used together to treat rat Walker carcinosarcoma 256, and the obvious protective effect on leucopenia caused by cyclophosphamide is found.
Other effects
The feed is added with betaine (4-6g/kg or 8g/kg), so as to increase the body weight of female and male chicks and increase egg production. Mouse gavage ginseng and wolfberry paste 1: 10 (0.2 ml/day) for 14 days, the weight of the animal can be obviously increased by 1 time more than that of a control group, and the animal has bright hair color, full muscle and bright red blood color. In addition, wolfberry fruit and betaine have protective effects on liver damage caused by CCl 4.
Dried mulberry fruit
The health-care tea has very strong health-care value, can tonify liver and kidney, enrich blood and maintain beauty, can improve sub-health and the like, and can better exert the effect by being matched with other medicines for soaking in water.
The dried mulberry and the medlar are matched, so that the kidney can be better tonified, the sexual function can be better improved, and particularly, the male sperm quality can be improved.
The dried mulberry can be matched with honey, so that the characteristic of acidity of the dried mulberry can be reduced, the honey can be used for neutralization, and the effects of relaxing bowel and health care can be achieved.
The mulberry has the effects of tonifying liver and kidney, promoting the production of body fluid, moistening dryness, improving eyesight and the like, and is a common fruit for promoting urination, protecting health and relieving summer heat. Generally, mulberries are harvested after fruits are ripe for 4 to 6 months every year, and the mulberries are used after being dried in the sun or slightly steamed and dried in the sun, or can be used for soaking in wine. The mulberry has high nutritive value and is an important value medical value and medical value. Mulberry has the effects of nourishing yin and blood, promoting the production of body fluid and moistening dryness, and is suitable for treating liver and kidney, yin and blood deficiency, body fluid deficiency, diabetes, intestinal dryness and other symptoms.
The dried mulberry is a common dried fruit, is sour, sweet and delicious in taste, contains abundant sugar, amino acid, vitamin, carotene, anthocyanin, selenium, iron, sodium, calcium and other mineral components, has high nutritive value, is considered by traditional Chinese medicine to enter liver and kidney channels, has multiple effects of nourishing yin and blood, promoting the secretion of saliva or body fluid and moistening intestines and the like, can be singly soaked in water for drinking, can be added with other medicinal materials with homology of medicine and food to be soaked in water for drinking, and has the following advantages: medlar, red dates, honey and the like.
Efficacy of
1. Replenishing blood and clearing blood and promoting the growth of hematopoietic cells, namely, women need to replenish blood and maintain beauty, the effects of the Chinese dates and the donkey-hide gelatin are more embodied in tonifying, and the mulberries have the effect of improving the hematopoietic function of the organism).
2. Anticancer, blood sugar and blood fat reducing mulberry fruit contains one kind of matter called "resveratrol" (RES) and can stimulate some genes in human body to inhibit the growth of cancer cell and prevent the formation of embolism in blood cell.
3. Beautifying and anti-aging, which is rich in vitamin C and other antioxidant components and can maintain beauty and keep young.
4. Tonifying liver and kidney, has good effect on tonifying kidney of men and women, and radically treats tinnitus and nourishes black hair.
5. Enhancing immunity, enhancing blood metabolism, and improving body constitution.
6. Nourishing brain and promoting intelligence development of children, and regulating excessive brain for adults with Mori fructus.
Modern research
The mulberry fruit is rich in glucose, sucrose, fructose, carotene, vitamins (A, B1, B2, PP and C), malic acid, succinic acid, tartaric acid, minerals such as calcium, phosphorus, iron, copper, zinc and the like. The nutritional value of the mulberry is 5 times of that of the apple, the resveratrol content of the mulberry is more than ten times of that of the grape, and through detection, the selenium content of the mulberry is up to 68ug/kg, the anthocyanin content is 1936mg/kg, and the resveratrol content is 0.365 mg/kg; the total amount of amino acid reaches 4.8 percent.
The dried mulberries can be eaten and used as medicines, and the traditional Chinese medicine believes that the mulberries are sweet and sour in taste, slightly cold in nature and capable of entering heart, liver and kidney channels, so that the dried mulberries are good fruits for nourishing and strengthening, nourishing heart and improving intelligence.
Has the effects of enriching blood and nourishing yin, promoting the production of body fluid to quench thirst, moistening intestine dryness and the like,
it can be used for treating dizziness, tinnitus, palpitation, dysphoria, insomnia, soreness of waist and knees, premature gray hair, diabetes, thirst, and constipation due to yin blood deficiency.
Modern pharmacological research also shows that the dried mulberry can supplement the lack of gastric juice, promote the digestion of gastric juice, stimulate gastric mucosa, promote the secretion of intestinal juice and promote the gastrointestinal peristalsis when entering the stomach, thereby having the effects of tonifying and strengthening.
It is to be noted that:
the medlar has obvious body warming effect, so people suffering from cold, fever, inflammation and diarrhea are best to eat separately; fructus Lycii can excite sexual nerve, and should not be taken by patients with hypersexuality; wolfberry fruit has high sugar content, and each 100 g of wolfberry fruit contains 19.3 g of sugar, so the wolfberry fruit should be used with cautions for diabetics.
Fourthly, almond
The Chinese traditional medicine book Ben Cao gang mu lists three main effects of the almond: moisten lung, clear food retention and dissipate stagnation. The food retention clearing means that the almond can help digestion and relieve constipation symptoms; the record of the modern practical traditional Chinese medicine is as follows: almond has laxative effect and tonic effect when taken orally. For the elderly and physically weak with chronic constipation, the effect of taking almond is better.
The sweet almond is a health food, and when the sweet almond is eaten in a proper amount, the content of cholesterol in a human body can be effectively controlled, and the risk of heart diseases and various chronic diseases can be obviously reduced. The vegetarian almond can supplement protein, trace elements and vitamins such as iron, zinc and vitamin E in time. The fat contained in sweet almond is essential for healthy people and is a highly unsaturated fat beneficial to heart. The sweet almond is high in protein content, and a large amount of fiber in the sweet almond can reduce hunger sensation of people, so that the sweet almond is beneficial to weight maintenance. Fibers benefit the intestinal tissue and can reduce the incidence of intestinal cancer, cholesterol levels, and the risk of heart disease. Therefore, the obese people select the sweet almonds as snacks, and the effect of controlling the weight can be achieved. Scientific research also shows that the sweet almond can promote skin microcirculation, make skin ruddy and glossy, and has the effect of beautifying.
The almond is rich in protein, fat, saccharide, carotene, vitamin B, vitamin C, vitamin P, calcium, phosphorus, iron and other nutrients. The content of carotene is second to that of mango in fruit, and almond is called anticancer fruit. The almond contains rich fatty oil and has the function of reducing cholesterol, so the almond has good function of preventing and treating cardiovascular system diseases; the theory of traditional Chinese medicine and traditional Chinese medicine is that the almond has the effects of promoting the production of body fluid to quench thirst, moistening lung and relieving asthma, and is commonly used for health care and treatment of patients with lung dryness, cough and asthma and the like. A recent research effort by american researchers has shown that people with normal or slightly elevated cholesterol levels can replace their diet with low-nutrient-density foods with almonds to achieve the goals of lowering blood cholesterol and maintaining heart health. Researchers believe that the combination of various nutrients, such as vitamin E, monounsaturated fat and dietary fiber, which are contained in almonds, can effectively reduce the risk of heart disease.
1. Ku xing ren can relieve cough and dyspnea, moisten intestines to relieve constipation, and treat lung disease, cough, etc.
2. Sweet almond and dry almond which is eaten daily are moist and have certain lung tonifying effect.
3. The almond also contains abundant flavonoid and polyphenol components, and the components can not only reduce the content of cholesterol in a human body, but also obviously reduce the risk of heart diseases and a plurality of chronic diseases.
4. The almond also has the effect of beautifying, and can promote skin microcirculation and make skin ruddy and glossy.
5. The almond also has an anti-tumor effect, and the almond mainly contains a bioactive substance, namely amygdalin, which can enter blood to kill cancer cells and has no effect on healthy cells, so that the almond can improve the symptoms of patients with advanced cancer and prolong the life of the patients. Meanwhile, because of containing rich carotene, the product can resist oxidation, prevent free radicals from invading cells and has the function of preventing tumors!
Is mainly used for treating diseases
1. Relieving cough and asthma
Semen Armeniacae amarum can be used for treating cough and asthma. It enters lung meridian. Bitter taste can descend, and has the action of dispersing and smoothing lung qi, so it is the essential herb for cough and dyspnea. It can be used for various cough and dyspnea syndromes with the combination of different syndromes. For example, Ma Huang and gan Cao are combined to dispel wind-cold and release lung qi to relieve dyspnea, such as cough and dyspnea due to wind-cold, that is, Sanao Tang. For cough due to wind-heat, sang Ye and Ju Hua are combined to dispel wind-heat, and to ventilate lung and relieve cough, as sang Ju Yin. For cough due to dryness-heat, it is combined with sang Ye, Bei mu and Sha Shen to clear lung heat, moisten dryness and relieve cough, as in sang xing Tang. For cough and dyspnea due to lung heat, it is combined with Shi Gao to clear lung heat, release heat, ventilate lung and relieve dyspnea, as in Ma xing Shi gan Tang.
2. Action on digestive System
The almond is bitter in taste and smells sweet, and is rich in fatty oil. The fatty oil can improve the lubricating effect of intestinal contents on mucous membrane, so the almond has the function of relaxing bowel.
3. Anti-inflammatory and analgesic effects
Benzaldehyde generated by amygdalin decomposition reacts with benzoin condensing enzyme to generate benzoin. The benzoin has the effect of relieving pain, so that the pain of patients can be relieved by using the bitter apricot seeds to treat the late liver cancer in China, and some people even do not need to take analgesics.
4. Anti-tumor effect
The research on the anti-tumor mechanism of almond mainly comprises the following aspects:
some researchers believe that cancer cells contain a large amount of beta-glucosidase, which hydrolyzes amygdalin to produce hydrocyanic acid (HCN), benzaldehyde, and glucose. Since cancer cells lack a thionitrile-producing enzyme, which has a detoxifying effect on HCN, HCN becomes a nontoxic thionitrile compound, while normal cells lack β -glucosidase and contain a large amount of thionitrile-producing enzyme. According to this theory, amygdalin should be able to selectively kill cancer cells while being almost harmless to normal cells.
② the amygdalin can help the trypsin digest the transparent mucin membrane of the cancer cell in vivo, so the leukocyte is more close to the cancer cell and swallows the cancer cell.
③ people find that amygdalin like NaSCN and NaOCN can affect the absorption of phosphate and amino acid when thymidine enters into hepatoma cell DNA and tumor cells.
5. Blood sugar lowering effect
Amygdalin has effects of preventing and treating diabetes caused by antineoplastic agent urea. The method for inducing hyperglycemia of mice by using the urea proves that the blood sugar is measured after 3g/kg of amygdalin is intraperitoneally injected for 48 hours in advance, the result shows that the amygdalin can specifically inhibit the blood sugar rise caused by the urea, and the action intensity is related to the concentration of the amygdalin in the blood.
6. Blood lipid reducing effect
Clinically, the almond can obviously reduce the blood fat level of patients with hyperlipidemia, and Spiller (1990) considers that monounsaturated fatty acid in the almond is helpful for reducing slightly elevated blood fat of patients without strict diet restriction.
7. Cosmetic effect
According to the theory of lung-joining skin and hair, some skin diseases can be clinically treated by lung-ventilating method, and quick effect is often obtained by matching with the almond. Modern researches have proved that the fatty oil contained in the bitter apricot seeds can soften the cuticle of the skin, thereby achieving the effect of beautifying.
8. Is used for treating constipation due to intestinal dryness
It is moist and greasy, bitter in taste and descending qi, so it can moisten intestines and relax bowels. It is often combined with Bai Zi ren and Yu Li ren, for instance, it is used in Wu ren Wan from Shi Yi De Xiao Fang.
9. Other effects
Amygdalin has anti-mutation effect, and can reduce the number of micronuclear polychromatic erythrocytes caused by analgin, metronidazole, mitomycin C, etc. The amygdalin hydrolysate benzaldehyde can inhibit the digestion function of pepsin in vitro and in healthy people or ulcer people, and has an anti-ulcer effect. The pepsin hydrolysate of the water-soluble fraction of almond is administered to rats treated with carbon tetrachloride, and has effects in inhibiting the increase of SGOT and SGPT levels and hydroxyproline content, and inhibiting the prolongation of euglobulin dissolution time.
The pepsin hydrolysate of almond has an inhibiting effect on the inflammation of mouse granuloma caused by writhing of mice and cotton balls caused by acetic acid, but does not inhibit the acute swelling of rat paw caused by carrageenan and the development of first-stage and second-stage injury of rat arthritis caused by adjuvant. In adjuvant-induced arthritis mice, the administration of the pepsin hydrolysate of almond for 2 months can prolong the dissolution time of euglobulin and inhibit the proliferation of abdominal artery connective tissue.
The bitter almond oil has the functions of expelling parasites and sterilizing, has the function of killing human ascaris and earthworms in vitro tests, and has the function of resisting typhoid fever and paratyphoid bacillus. The semen Armeniacae amarum also has effects in resisting enterobiasis and trichomonad infection, and treating aplastic anemia.
Experiments show that: the bitter almond decoction has the function of promoting total phosphorus synthesis for normal rabbits, and obtains a pathological improvement result for treating oleic acid adult rabbit respiratory distress syndrome. The bitter apricot seeds can promote the synthesis of lung surfactant, and can be used for clinically treating adult respiratory distress syndrome.
Wu, gan Jiang
Nature and taste: pungent flavor and warm property.
Meridian tropism: it enters spleen, stomach, kidney, heart and lung meridians.
The efficacy is as follows: warming the middle energizer to dispel cold, restoring yang to activate collaterals, warming the lung to resolve retained fluid.
The main treatment is as follows: can be used for treating abdominal psychroalgia, emesis, diarrhea, cold limbs, slight pulse, cough and asthma due to cold fluid retention.
Compendium of materia Medica: gan Jiang can induce blood to enter blood system and qi to enter qi system. It is indicated for blood deficiency because it can remove aversion to nourishment new skin and has the meaning of growing yin from yang. It is also indicated for hematemesis, epistaxis and bleeding with yin and yang deficiency, and it is also indicated for heat-induced syndrome.
Sixthly, licorice root
Neutral in nature and sweet in flavor, it enters twelve meridians. Has the pharmacological actions of detoxification, phlegm elimination, pain relief, spasmolysis and cancer resistance. In traditional Chinese medicine, liquorice tonifies spleen and qi, relieves cough and moistens lung, relieves urgency and detoxifies, and regulates a plurality of medicines. Clinical applications are divided into unprocessed and honey-processed. Stir-baked with honey is mainly indicated for hypofunction of spleen and stomach, loose stool, weakness, fever, cough, palpitation, etc.
Licorice root is indicated for heart-qi deficiency, palpitation, intermittent pulse, spleen-stomach qi deficiency, lassitude and hypodynamia.
Nutritive value of licorice
1. Licorice root has the similar effect of adrenocortical hormone. Has inhibitory effect on hyperacidity caused by histamine; it also has antacid and spasmodic effects on smooth muscle of stomach and intestine.
2. Licoflavone, glycyrrhiza extract and glycyrrhetinic acid have obvious cough relieving effect; the phlegm eliminating effect is also obvious, and the action strength is glycyrrhizic acid, licoflavone and liquorice extract.
3. The Glycyrrhrizae radix has antiinflammatory and antiallergic effects, and can protect inflamed throat and trachea mucosa. The glycyrrhiza extract and glycyrrhizic acid have detoxifying effect similar to that of glucuronic acid on certain toxicants.
4. Licorice is commonly used to treat symptoms accompanying menopause because it contains liquiritigenin, a hormone-like compound that helps to balance the hormone content in women.
5. The hypochlorous acid contained in Glycyrrhrizae radix can block carcinogen from inducing tumor growth.
Seventhly, stir-fried radish seed
1. For treating constipation of the old:
senile constipation is similar to the spleen in Shang Han Lun. The spleen failing to transport the body fluids through the stomach is called spleen qi, so it is difficult to urinate and defecate. For frequent micturition due to constipation, 15g of parched radish seeds are ground into fine powder and taken with boiled water after meal, so as to promote digestion and direct qi flow without hurting qi, which can be taken in more food and drink and the qi is self-nourished (see "Zhongzhao Xi Lu of medicine)". The persistence is constant, the stomach yin is lowered to make the dregs go well, and the benefit is very strong. In clinical practice, the effect is usually achieved by removing the old and relieving the stasis to relieve constipation, and the four methods of cold, warm, moistening and purgation are not limited, but stir-frying radish seeds is added according to the syndrome.
2. Stir-baked for resolving phlegm and relieving asthma:
the book of Nei Jing Yun: "gather in the stomach and relate to the lung. The spleen and stomach are abnormal in receiving, transporting, ascending and descending, and the dampness and turbidity in the food is collected in the stomach to form phlegm. Phlegm of the lung is caused by the failure of the lung to clear and descend due to pathogenic factors. Lai Fu Zi is used to promote digestion, resolve phlegm, descend qi and relieve dyspnea, so that the body resistance is not accumulated. Semen Raphani can be used to stop the source of phlegm; without phlegm, it regulates qi movement of spleen and stomach, ascending and descending with degree, and it is difficult to store pathogenic factors.
The main components are as follows:
contains fatty oil and volatile oil. The volatile oil contains Methyl mercaptan (Methyl mercaptan). The fatty oil contains high content of Erucic acid (Erucic acid), linoleic acid, linolenic acid, and Erucic acid glyceride (Glycerol sinapate). Further contains Raphani semen (Raphanin). Separating to obtain beta-Sitosterol (beta-Sitosterol)
Pharmacological action
1. The effect experiment on gastrointestinal motility shows that: the raw radish seed and the fried and roasted products can increase the contraction amplitude of the isolated rabbit intestine, but have no obvious influence on the tension of the isolated rabbit intestine; all three products were able to counteract the inhibitory effect of epinephrine on the gut. The crude radish seed can reduce the tension of guinea pig stomach muscle, and the fried radish seed and the roasted radish seed can firstly increase the tension and then reduce the tension. The three products can increase the contraction amplitude of the gastric muscle strips; the tension and contraction amplitude of the ring muscles of the stomach pylorus are increased. The fried radish seeds have obvious propulsion effect on the small intestine of a mouse; the three preparations have inhibitory effect on gastric emptying of mice.
2. The radish seed water infusion (1:3) with the effect of resisting pathogenic microorganisms has different degrees of inhibition effects on dermatophytes such as trichophyton concentricum, yellow ringworm of the orchid, ozocellum ozoenlum, microsporum ferrugineum, microsporum laniforme, nocardia stellata and the like in a test tube. The Raphani semen contains antibacterial substance, and its effective component is Raphani semen. Has obvious inhibiting effect on staphylococcus and colon bacillus; it also has effects in inhibiting growth of streptococcus, pyococcus, pneumococcus, and Escherichia coli. The sulforaphane also has inhibitory effect on virus, and DNA virus is more sensitive than RNA virus.
3. The radish seed water-alcohol extract with the blood pressure reducing effect is injected into the veins of cats and dogs, and has very obvious blood pressure reducing effect; the extract has obvious blood pressure lowering effect for rabbit and kidney type hypertensive rat. The report suggests that the blood pressure lowering effect of radish seeds is irrelevant to sympathetic nerves, a large amount of atropine or cutting off vagus nerves at two sides cannot block the blood pressure lowering effect of radish seeds, and the relationship between the blood pressure lowering mechanism and the M-choline reaction is not large; procaine can reduce the blood pressure reduction amplitude of the radish seed, and indicates that an intravascular receptor is possibly related to the pharmacological action of the radish seed. Experiments prove that: the radish seeds have the function of relaxing intestinal canal smooth muscles and increasing the blood flow volume of the limb of the dog, which shows that the radish seeds have the function of expanding blood vessels; the vertebral artery administration has blood pressure lowering effect on rabbit and cat. Therefore, it is considered that the drug exerts its hypotensive effect partially through the central nervous system in addition to the direct vasodilatory effect on blood vessels to cause hypotensive effect. Experiments also show that: the radish seed injection has obvious effect of reducing acute hypoxic pulmonary hypertension and body arterial pressure of rabbits; the radish seed dosage is increased, the intensity of reducing the pressure of the lung and the body arteries is increased, and compared with phentolamine, the radish seed can obviously prolong the pressure reduction time.
4. Other effects rats fed with radish seed extract for a long time can interfere their thyroxine synthesis. The radish seed water extract is injected into the abdominal cavity of a rat, has obvious inhibition effect on inflammatory hyperplasia of oily granuloma of croton, but has weaker anti-permeability effect. The beta-sitosterol separated and extracted from the radish seeds has certain effects of relieving cough and eliminating phlegm, and provides theoretical basis for the radish seeds to treat tracheitis; the composition can treat the increase of serum cholesterol of a human body and prevent coronary atherosclerosis, and has a certain effect on the aspect of treating coronary heart disease.
The invention and its embodiments have been described above, without this being limitative. In summary, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (2)
1. The formula of the cinnamon, medlar, ginger and sweet tea is characterized in that: comprises the following components by weight: 0.25 part of cinnamon, 1.5 parts of medlar, 0.25 part of dried mulberry, 1 part of fried almond, 0.5 part of dried ginger, 1 part of honey-fried licorice root and 0.5 part of fried radish seed.
2. The formula of the cinnamon, medlar, ginger and sweet tea and the preparation method thereof are characterized in that: comprises the following preparation steps of the following steps of,
(1) preparing raw materials according to the weight parts, namely 0.25g of cinnamon, 1.5g of medlar, 0.25g of dried mulberry, 1g of fried almond, 0.5g of dried ginger, 1g of honey-fried licorice root and 0.5g of fried radish seed;
(2) the raw materials are ground into powder, and each bag is 5g, and the powder is taken with water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111033875.8A CN113662068A (en) | 2021-09-03 | 2021-09-03 | Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111033875.8A CN113662068A (en) | 2021-09-03 | 2021-09-03 | Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113662068A true CN113662068A (en) | 2021-11-19 |
Family
ID=78548450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111033875.8A Withdrawn CN113662068A (en) | 2021-09-03 | 2021-09-03 | Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113662068A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114272354A (en) * | 2022-02-21 | 2022-04-05 | 澳门大学 | Traditional Chinese medicine composition for preventing and improving senile dementia, its preparation method and its application |
-
2021
- 2021-09-03 CN CN202111033875.8A patent/CN113662068A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114272354A (en) * | 2022-02-21 | 2022-04-05 | 澳门大学 | Traditional Chinese medicine composition for preventing and improving senile dementia, its preparation method and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102511869B (en) | Thickened red jujube ginger pulp | |
| CN103652361A (en) | Feed for postpartum sow in lactation period of 1-20 days and preparation method thereof | |
| CN104381691A (en) | Functional feed for preventing nutritional anemia of piglets and preparation method of functional feed | |
| CN104489516A (en) | Health-preserving porridge capable of improving postoperative immune function of cancer paint and preparation method for health-preserving porridge | |
| CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
| CN101467582A (en) | Refined lift-lengthening tea | |
| CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
| CN106858215A (en) | A kind of passion fruit composite beverage | |
| CN103461585B (en) | Qi tonifying and health preserving herbal tea | |
| KR20130063074A (en) | Blood glucose and blood pressure decrease action composition | |
| CN106983073A (en) | A kind of health-maintaining noodles containing astaxanthin and preparation method thereof | |
| CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
| KR102192573B1 (en) | Composition for preventing and improving menstrual pain and skin troubles | |
| CN105249440A (en) | Donkey-hide gelatin cake | |
| CN113662068A (en) | Formula and preparation method of osmanthus fragrans, medlar, ginger and sweet tea | |
| CN110583974A (en) | Slimming whole grain nutritional and healthy meal replacement food and preparation method thereof | |
| CN104544084B (en) | A kind of health food for diabetics | |
| CN101496604A (en) | Nutrient foodstuffs with function for reducing blood fat and preparation method thereof | |
| CN104783174A (en) | Preparation method of pure natural nutritional, immune and health solid beverage | |
| KR20180056199A (en) | Manufacturing method of gum for diet containing Moringa Oleifera extract | |
| CN117084404A (en) | A composition for preventing disease and preparation method thereof | |
| CN106562196A (en) | Health-care food for patients suffering from chronic indigestion to eat, and preparation method of health-care food | |
| CN112691179A (en) | Traditional Chinese medicine composition for losing weight and preparation method thereof | |
| CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
| CN114748583A (en) | Traditional Chinese medicine liquor for nourishing and preserving health |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20211119 |